Court declined to review a federal appeals court ruling that found people with gender dysphoria were entitled to protections under the Americans With Disabilities Act

Findings based on survey encompassing six clinical contexts involving heightened risk for firearm injury

No impact on receipt of opioid or nonopioid pain treatment seen among patients with chronic noncancer pain

Strongest demographic predictor for discharge initiation of medications for alcohol use disorder was younger age

Improvement in global cognition seen for patients with Alzheimer disease/MCI, but no effects seen for healthy individuals, other patient populations

Increased rates seen for suicide attempts, suicide mortality, suicide-unrelated mortality, all-cause mortality versus nontransgender individuals

Increase seen in age-adjusted rate of drug overdose deaths involving xylazine from 0.03 to 1.06 per 100,000 standard population

$500,000 increase in penalty linked to a 2.9 percentage point increase in compliance

Over the same time period, age of gender dysphoria diagnosis dropped

Severity of grief tied to greater increases in blood pressure